p53-dependent association between cyclin G and the B' subunit of protein phosphatase 2A

Molecular and Cellular Biology

Volumn 16, Issue 11, 1996, Pages 6593-6602

  Okamoto, Koji ^a,c   Kamibayashi, Craig ^b   Serrano, Manuel ^a   Prives, Carol ^c   Mumby, Marc C ^b   Beach, David ^a,d  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL TRANSFORMATION; DEPHOSPHORYLATION; HYPOXIA; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STRESS; TEMPERATURE SENSITIVE MUTANT; TRANSCRIPTION REGULATION;

ANIMALIA; MAMMALIA;

EID: 0029827632     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.11.6593     Document Type: Article

References (48)

1. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (London) 377:552-557.
2. Buckbinder, L., R. Talbott, S. Velasco-Miguel, I. Takenaka, B. Faha, B. R. Seizinger, and N. Kley. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature (London) 377:646-649.
3. 0. J. Biol. Chem. 271:2578-2588.
4. Deng, C., P. Zhang, W. J. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21/CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
5. Draetta, G. 1990. Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation. Trends Biochem. Sci. 15:378-383.
6. Dulic, V., W. K. Kaufman, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
7. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
8. Graeber, T. G., C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe, and A. J. Giaccia. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (London) 379:88-91.
9. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:6264-6277.
10. Guan, K., and J. E. Dixon. 1991. Eukaryotic proteins expressed in Escheriehia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 192:262-267.
11. Hannon, G. J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7:2378-2391.
12. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
13. Heichman, K. A., and J. M. Roberts. 1994. Rules to replicate by. Cell 79: 557-562.
14. Hendrix, P., R. E. Mayer-Jacket, P. Cron, J. Goris, J. Hofsteenge, W. Merlevede, and B. A. Hemmigs. 1993. Structure and expression of a 72-kDa regulatory subunit of protein phosphatase 2A. Evidence for different size forms produced by alternative splicing. J. Biol. Chem. 268:15267-15276.
15. Hollstein, M., K. Rice, M. S. Greenblatt, T. Soussi, R. Fuchs, T. Sorlie, E. Hovig, B. Smith-Sorensen, R. Montesano, and C. C. Harris. 1994. Database at p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22:3551-3555.
16. Horne, M. C., G. L. Goolsby, K. L. Donaldson, D. Tran, M. Neubauer, and A. F. Wahl. 1996. Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expressions. J. Biol. Chem. 271:6050-6061.
17. Juven, T., Y. Barak, A. Zauberman, D. L. George, and M. Oren. 1993. Wild-type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8:3411-3416.
18. Kamibayashi, C., R. Estes, R. L. Lickteig, S. I. Yang, C. Craft, and M. C. Mumby. 1994. Comparison of heterotrimeric protein phosphatase 2A containing different B subunits. J. Biol. Chem. 269:20139-20148.
19. Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-teleangicetasia. Cell 71:587-597.
20. Kleinberger, T., and T. Shenk. 1993. Adenovirus E4orf4 protein hinds to protein phosphatase 2A and the complex down regulates E1A-enhanced jumB transcription. J. Virol. 67:7556-7560.
21. Knudson, C. M., K. S. Tung, W. G. Tourtellotte, G. A. Brown, and S. Korsmeyer. 1995. Bax-deficient mice with lymphoid hyperplasia and male germ cell growth. Science 270:96-99.
22. Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
23. Mayer, R. E., P. Hendrix, P. Cron, R. Matthies, S. R. Stone, J. Goris, W. Merlevede, J. Hofsteenge, and B. A. Hemmings. 1991. Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neural-specific isoform. Biochemistry 30:3589-3597.
24. Mayer-Jaekel, R. E., and B. A. Hemmings. 1994. Protein phosphatase 2A - a 'menage a trois'. Trends Cell Biol. 4:287-291.
25. McCright, B., and D. M. Virshup. 1995. Identification of a new family of protein phosphatase 2A regulatory subunits. J. Biol. Chem. 270:26123-26128.
26. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
27. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
28. Okamoto, K., and D. Beach. 1994. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13:4816-4822.
29. Pallas, D. C., L. K. Sharrik, B. L. Martin, S. Jaspers, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167-176.
30. Renzing, J., and D. Lane. 1995. p53-dependent growth arrest following calcium phosphate-mediated transfection of murine cells. Oncogene 10: 1865-1868.
31. Rosenblum-Vos, L. S., L. Rhodes, C. C. Evangelista, K. A. Boayke, and R. S. Zitomer. 1991. The ROX3 gene encodes an essential nuclear protein involved in CYC7 gene expression in Saccharomyces cerevisiae. Mol. Cell. Biol. 11:5639-5647.
32. Shu, Y., and R. L. Hallberg. 1995. SCS1, a muticopy suppressor of hsp-ts mutant alleles, does not encode a mitochondrially targeted protein. Mol. Cell. Biol. 15:5618-5626.
33. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glulathione S-transferase. Gene 67:31-40.
34. Sugano, T., M. Nitta, H. Ohmori, and M. Yamaizumi. 1995. Nuclear accumulation of p53 in normal human fibroblasts is induced by various cellular stresses which evoke the heat shock response, independently of the cell cycle. Jpn. J. Cancer Res. 86:415-418.
35. Tamura, K., Y. Kanaoka, S. Jinno, A. Nagata, Y. Ogiso, K. Shimizu, T. Hayakawa, H. Nojima, and H. Okayama. 1993. CyclinG: a new mammalian cyclin with homology to fission yeast Cig1. Oncogene 8:2113-2118.
36. Tehrani, M. A., M. C. Mumby, and C. Kamibayashi. 1996. Identification of a novel protein phosphatase 2A regulatory subunit highly expressed in muscle. J. Biol. Chem. 271:5164-5170.
37. Vogelstein, B., and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70:523-536.
38. Walter, G., and M. Mumby. 1993. Protein serine/threonine phosphatases and cell transformation. Biochim. Biophys. Acta 1155:207-226.
39. Walter, G., and M. C. Mumby. 1993. Protein serine/threonine phosphatases: structure, regulation, and function in cell growth. Physiol. Rev. 73:673-699.
40. Walter, G., R. Ruediger, C. Slaughter, and M. Mumby. 1910. Association of protein phosphatase 2A with polyoma virus medium tumor antigen. Proc. Natl. Acad. Sci. USA 87:2521-2525.
41. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15.
42. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.
43. Xiong, Y., G. H. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature (London) 366: 701-704.
44. Yonish-Rouash, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature (London) 352:345-347.
45. Zauberman, A., A. Lupo, and M. Oren. 1995. Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene cantains two distinct p53 binding sites. Oncogene 10:2361-2366.
46. skp2 are essential elements of the cyclin A-cdk 2 S phase kinase. Cell 82:915-925.
47. Zhang, H., Y. Xiong, and D. Beach. 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4:897-906.
48. Zhang, W., C. McClain, J. P. Gau, X. Y. Guo, and A. B. Deisseroth. 1994. Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function. Cancer Res. 54:4448-4453.